New global guidelines on the treatment of heart failure strongly endorse the use of Novartis’ Entresto, boosting the prospects for a drug that has struggled to...
If the pharma giant doesn’t cut prices, it could lose its patent protection to generics. Colombia’s government is giving pharmaceutical giant Novartis a few weeks to...